Literature DB >> 21703993

Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging.

Suphiya Parveen1, Ranjita Misra, Sanjeeb K Sahoo.   

Abstract

Drug delivery is an interdisciplinary and independent field of research and is gaining the attention of pharmaceutical researchers, medical doctors and industry. A safe and targeted drug delivery could improve the performance of some classic medicines already on the market, and moreover, will have implications for the development and success of new therapeutic strategies such as anticancer drug delivery, peptide and protein delivery and gene therapy. In the last decade, several drug-delivery technologies have emerged and a fascinating part of this field is the development of nanoscale drug delivery devices. Nanoparticles (NPs) have been developed as an important strategy to deliver conventional drugs, recombinant proteins, vaccines and more recently, nucleotides. NPs and other colloidal drug-delivery systems modify the kinetics, body distribution and drug release of an associated drug. This review article focuses on the potential of nanotechnology in medicine and discusses different nanoparticulate drug-delivery systems including polymeric NPs, ceramic NPs, magnetic NPs, polymeric micelles and dendrimers as well as their applications in therapeutics, diagnostics and imaging. FROM THE CLINICAL EDITOR: This comprehensive review focuses on different nanoparticulate drug-delivery systems including polymeric NPs, ceramic NPs, magnetic NPs, polymeric micelles and dendrimers as well as their applications in therapeutics, diagnostics and imaging.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21703993     DOI: 10.1016/j.nano.2011.05.016

Source DB:  PubMed          Journal:  Nanomedicine        ISSN: 1549-9634            Impact factor:   5.307


  188 in total

Review 1.  Nanoparticle delivery systems for cancer therapy: advances in clinical and preclinical research.

Authors:  Susana Patricia Egusquiaguirre; Manuela Igartua; Rosa María Hernández; José Luis Pedraz
Journal:  Clin Transl Oncol       Date:  2012-02       Impact factor: 3.405

Review 2.  Nanotherapeutic approaches for the treatment of rheumatoid arthritis.

Authors:  Christine T N Pham
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2011-08-11

Review 3.  Strategies to target tumors using nanodelivery systems based on biodegradable polymers, aspects of intellectual property, and market.

Authors:  Michele F Oliveira; Pedro P G Guimarães; Alinne D M Gomes; Diego Suárez; Rubén D Sinisterra
Journal:  J Chem Biol       Date:  2012-11-30

4.  Meeting report VLPNPV: Session 5: Plant based technology.

Authors:  Lydia R Meador; Tsafrir S Mor
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

5.  Development of oxaliplatin encapsulated in magnetic nanocarriers of pectin as a potential targeted drug delivery for cancer therapy.

Authors:  Raj Kumar Dutta; Saurabh Sahu
Journal:  Results Pharma Sci       Date:  2012-05-22

Review 6.  The role of radionuclide probes for monitoring anti-tumor drugs efficacy: A brief review.

Authors:  Renata Salgado Fernandes; Carolina de Aguiar Ferreira; Daniel Cristian Ferreira Soares; Anna Margherita Maffione; Danyelle M Townsend; Domenico Rubello; André Luís Branco de Barros
Journal:  Biomed Pharmacother       Date:  2017-09-12       Impact factor: 6.529

7.  Modality switching between therapy and imaging based on the excitation wavelength dependence of dual-function agents in folic acid-conjugated graphene oxides.

Authors:  Seung Won Jun; Junyoung Kwon; Soo Kyung Chun; Hyun Ah Lee; Jaebeom Lee; Dae Youn Hwang; Chen-Yuan Dong; Chang-Seok Kim
Journal:  Biomed Opt Express       Date:  2018-01-22       Impact factor: 3.732

8.  Docetaxel-loaded liposomes: preparation, pH sensitivity, pharmacokinetics, and tissue distribution.

Authors:  Hong Zhang; Rui-ying Li; Xia Lu; Zhen-zhen Mou; Gui-mei Lin
Journal:  J Zhejiang Univ Sci B       Date:  2012-12       Impact factor: 3.066

9.  Combination-targeting to multiple endothelial cell adhesion molecules modulates binding, endocytosis, and in vivo biodistribution of drug nanocarriers and their therapeutic cargoes.

Authors:  Iason Papademetriou; Zois Tsinas; Janet Hsu; Silvia Muro
Journal:  J Control Release       Date:  2014-06-14       Impact factor: 9.776

10.  Targeting of BRAF resistant melanoma via extracellular matrix metalloproteinase inducer receptor.

Authors:  Matthew R Zeiderman; Michael E Egger; Charles W Kimbrough; Christopher G England; Tess V Dupre; Kelly M McMasters; Lacey R McNally
Journal:  J Surg Res       Date:  2014-02-20       Impact factor: 2.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.